13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2018-02-13 Event — SEC 0000903423-18-000105 →

GLAXOSMITHKLINE PLC → CRISPR Therapeutics AG CRSP

Stake: — Shares: —
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100
  • Passive Schedule 13G filer baseline
  • Held by 1 tracked 13F institutional manager
  • Elevated short days-to-cover (10.2 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
47 transactions
8 buys · 22 sales · 17 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
23 filings by this filer
22 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 10.23
16,442,415 shares short · -12.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $2.69M
Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-03-23 Prasad Raju officer Sale 3,708 $46.78 $173K
2026-03-23 Kulkarni Samarth director, officer Sale 10,020 $46.78 $469K
2026-03-23 KASINGER JAMES R. officer Sale 3,182 $46.78 $149K
2026-03-20 KASINGER JAMES R. officer Option exercise 6,250 — —
2026-03-20 Kulkarni Samarth director, officer Option exercise 19,687 — —
2026-03-20 Prasad Raju officer Option exercise 6,250 — —
2026-03-20 Patel Naimish officer Award 38,499 $46.24 $1.78M
2026-03-20 Patel Naimish officer Award 30,000 — —
2026-03-20 Prasad Raju officer Award 38,499 $46.24 $1.78M
2026-03-20 Prasad Raju officer Award 27,500 — —
2026-03-20 Kulkarni Samarth director, officer Award 114,249 $46.24 $5.28M
2026-03-20 Kulkarni Samarth director, officer Award 81,875 — —
2026-03-20 KASINGER JAMES R. officer Award 38,499 $46.24 $1.78M
2026-03-20 KASINGER JAMES R. officer Award 25,000 — —
2026-03-16 Kulkarni Samarth director, officer Sale 10,349 $48.26 $499K
2026-03-16 KASINGER JAMES R. officer Sale 3,450 $48.26 $166K
2026-03-16 Prasad Raju officer Sale 5,848 $48.26 $282K
2026-03-16 Prasad Raju officer Sale 4,021 $48.26 $194K
2026-03-16 Prasad Raju officer Gift 750 — —
2026-03-16 Patel Naimish officer Sale 3,150 $48.26 $152K
2026-03-14 Patel Naimish officer Option exercise 8,125 — —
2026-03-14 Prasad Raju officer Option exercise 10,000 — —
2026-03-14 KASINGER JAMES R. officer Option exercise 6,875 — —
2026-03-14 Kulkarni Samarth director, officer Option exercise 20,625 — —
2026-03-14 Prasad Raju officer Option exercise 6,875 — —
Showing 25 of 47

Other 13D/G Filings on CRISPR Therapeutics AG

FiledFormFilerStakeShares
2021-02-16 SC Versant Ventures IV, LLC — — view →
2020-02-04 SC Bayer Global Investments B.V. — — view →
2020-01-24 SC Bayer Global Investments B.V. — — view →
2019-06-07 SC VERTEX PHARMACEUTICALS INC / MA — — view →
2018-02-08 SC CELGENE CORP /DE/ — — view →
2018-01-16 SC Abingworth LLP — — view →

Other Filings by GLAXOSMITHKLINE PLC

FiledFormIssuerStakeShares
2023-10-10 SC Haleon plc HLNCF — — view →
2022-11-14 SC Spero Therapeutics, Inc. SPRO — — view →
2022-09-20 SC Theravance Biopharma, Inc. TBPH — — view →
2022-02-10 SC Theravance Biopharma, Inc. TBPH — — view →
2021-09-16 SC Spero Therapeutics, Inc. SPRO — — view →
2021-09-16 SC BICYCLE THERAPEUTICS plc BCYC — — view →
2021-05-25 SC Innoviva, Inc. INVA — — view →
2021-04-16 SC BICYCLE THERAPEUTICS plc BCYC — — view →
2021-04-08 SC Pandion Therapeutics, Inc. — — view →
2021-02-12 SC Innoviva, Inc. INVA — — view →
2020-12-07 SC Spero Therapeutics, Inc. SPRO — — view →
2020-12-07 SC BICYCLE THERAPEUTICS plc BCYC — — view →
2020-10-01 SC Principia Biopharma Inc. — — view →
2020-06-29 SC Morphic Holding, Inc. — — view →
2020-06-22 SC Theravance Biopharma, Inc. TBPH — — view →
2020-06-04 SC Spero Therapeutics, Inc. SPRO — — view →
2020-02-27 SC Theravance Biopharma, Inc. TBPH — — view →
2019-04-18 SC Theravance Biopharma, Inc. TBPH — — view →
2018-07-17 SC Spero Therapeutics, Inc. SPRO — — view →
2018-04-10 SC Innoviva, Inc. INVA — — view →
Showing 20 of 22

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →